Article
Transitions Optical Inc. released its enhanced version of the Transitions Online Marketing Tool during an exhibit at the Vision Expo East meeting in New York.
4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Study validates long-term efficacy of MicroPulse TLT for glaucoma management
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Viridian announces topline data from THRIVE-2 phase 3 clinical trial of veligrotug for treatment of thyroid eye disease
Aurion Biotech announces topline results from Phase 1/2 trial of AURN001 for corneal edema